Innoviva, Inc. 13D and 13G filings for Armata Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2025-03-12 5:49 pm Unchanged | 2025-03-12 | 13D | Armata Pharmaceuticals, Inc. ARMP | Innoviva Inc. INVA | 64,178,259 85.200% | 0 (Unchanged) | Filing |
2024-11-14 4:17 pm Unchanged | 2024-11-12 | 13D | Armata Pharmaceuticals, Inc. ARMP | Innoviva Inc. INVA | 64,178,259 85.200% | 0 (Unchanged) | Filing |
2024-03-04 5:35 pm Unchanged | 2024-03-04 | 13D | Armata Pharmaceuticals, Inc. ARMP | Innoviva Inc. INVA | 64,178,259 85.300% | 0 (Unchanged) | Filing |
2023-07-11 08:27 am Unchanged | 2023-07-10 | 13D | Armata Pharmaceuticals, Inc. ARMP | Innoviva Inc. INVA | 64,178,259 85.300% | 0 (Unchanged) | Filing |
2023-01-10 5:12 pm Purchase | 2023-01-10 | 13D | Armata Pharmaceuticals, Inc. ARMP | Innoviva Inc. INVA | 64,178,259 85.300% | 19,736,843![]() (+44.41%) | Filing |
2022-07-11 5:27 pm Sale | 2022-07-07 | 13D | Armata Pharmaceuticals, Inc. ARMP | Innoviva Inc. INVA | 100 100.000% | -57,345,694![]() (-100.00%) | Filing |
2022-05-23 8:55 pm Unchanged | 2022-05-23 | 13D | Armata Pharmaceuticals, Inc. ARMP | Innoviva Inc. INVA | 57,345,794 74.930% | 0 (Unchanged) | Filing |
2022-04-01 4:50 pm Purchase | 2022-03-31 | 13D | Armata Pharmaceuticals, Inc. ARMP | Innoviva Inc. INVA | 44,441,416 80.100% | 8,077,812![]() (+22.21%) | Filing |
2022-03-15 09:00 am Unchanged | 2022-03-15 | 13D | Armata Pharmaceuticals, Inc. ARMP | Innoviva Inc. INVA | 57,345,794 74.930% | 0 (Unchanged) | Filing |
2022-02-18 8:47 pm Unchanged | 2022-02-17 | 13D | Armata Pharmaceuticals, Inc. ARMP | Innoviva Inc. INVA | 57,345,794 75.150% | 0 (Unchanged) | Filing |
2022-02-11 3:15 pm Purchase | 2022-02-09 | 13D | Armata Pharmaceuticals, Inc. ARMP | Innoviva Inc. INVA | 36,363,604 76.700% | 5,422,188![]() (+17.52%) | Filing |
2022-02-01 6:34 pm Unchanged | 2022-02-01 | 13D | Armata Pharmaceuticals, Inc. ARMP | Innoviva Inc. INVA | 57,345,794 75.150% | 0 (Unchanged) | Filing |
2021-11-01 09:27 am Purchase | 2021-10-28 | 13D | Armata Pharmaceuticals, Inc. ARMP | Innoviva Inc. INVA | 30,941,416 73.800% | 30,941,416![]() (New Position) | Filing |
2021-06-11 5:37 pm Purchase | 2021-06-11 | 13D | Armata Pharmaceuticals, Inc. ARMP | Innoviva Inc. INVA | 57,345,794 75.500% | 29,345,794![]() (+104.81%) | Filing |
2021-04-05 5:07 pm Sale | 2021-04-01 | 13D | Armata Pharmaceuticals, Inc. ARMP | Innoviva Inc. INVA | 0 0.000% | -29,729,294![]() (Position Closed) | Filing |
2021-03-17 5:17 pm Purchase | 2021-03-17 | 13D | Armata Pharmaceuticals, Inc. ARMP | Innoviva Inc. INVA | 29,729,294 74.700% | 8,571,870![]() (+40.51%) | Filing |
2021-01-27 5:30 pm Purchase | 2021-01-26 | 13D | Armata Pharmaceuticals, Inc. ARMP | Innoviva Inc. INVA | 21,157,424 68.000% | 3,735,824![]() (+21.44%) | Filing |
2020-08-31 3:10 pm Unchanged | 2020-08-27 | 13D | Armata Pharmaceuticals, Inc. ARMP | Innoviva Inc. INVA | 28,000,000 67.800% | 0 (Unchanged) | Filing |
2020-06-12 5:30 pm Purchase | 2020-06-11 | 13D | Armata Pharmaceuticals, Inc. ARMP | Innoviva Inc. INVA | 28,000,000 67.800% | 28,000,000![]() (New Position) | Filing |